Literature DB >> 25323865

Parkinson Disease Genetics: A "Continuum" from Mendelian to Multifactorial Inheritance.

S Petrucci, F Consoli, E M Valente1.   

Abstract

Parkinson Disease (PD) is a common neurodegenerative disorder of intricate etiology, caused by progressive loss of aminergic neurons and accumulation of Lewy bodies. The predominant role of genetics in the etiology of the disease has emerged since the identification of the first pathogenetic mutation in SNCA (alpha-synuclein) gene, back in 1997. Mendelian parkinsonisms, a minority among all PD forms, have been deeply investigated, with 19 loci identified. More recently, genome wide association studies have provided convincing evidence that variants in some of these genes, as well as in other genes, may confer an increased risk for late onset, sporadic PD. Moreover, the finding that heterozygous mutations in the GBA gene (mutated in Gaucher disease) are among the strongest genetic susceptibility factors for PD, has widened the scenario of PD genetic background to enclose a number of genes previously associated to distinct disorders, such as genes causative of spinocerebellar ataxias, mitochondrial disorders and fragile X syndrome. At present, the genetic basis of PD defines a continuum from purely mendelian forms (such as those caused by autosomal recessive genes) to multifactorial inheritance, resulting from the variable interplay of many distinct genetic variants and environmental factors. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Genetics; Parkinson disease; monogenic; multifactorial; parkinsonism; risk factor

Year:  2014        PMID: 25323865     DOI: 10.2174/1566524014666141010155509

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  16 in total

Review 1.  Next generation sequencing in endocrine practice.

Authors:  Gregory P Forlenza; Amy Calhoun; Kenneth B Beckman; Tanya Halvorsen; Elwaseila Hamdoun; Heather Zierhut; Kyriakie Sarafoglou; Lynda E Polgreen; Bradley S Miller; Brandon Nathan; Anna Petryk
Journal:  Mol Genet Metab       Date:  2015-05-03       Impact factor: 4.797

2.  Genetic Paradoxes in an Italian Family with PARK2 Multiexon Duplication.

Authors:  Simona Petrucci; Gina Ferrazzano; Monia Ginevrino; Manuela Tolve; Isabella Berardelli; Alfredo Berardelli; Giovanni Fabbrini; Enza Maria Valente
Journal:  Mov Disord Clin Pract       Date:  2017-09-08

3.  Brain Connectivity Changes in Autosomal Recessive Parkinson Disease: A Model for the Sporadic Form.

Authors:  Elena Makovac; Mara Cercignani; Laura Serra; Mario Torso; Barbara Spanò; Simona Petrucci; Lucia Ricciardi; Monia Ginevrino; Carlo Caltagirone; Anna Rita Bentivoglio; Enza Maria Valente; Marco Bozzali
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

Review 4.  Glial Cells and Brain Diseases: Inflammasomes as Relevant Pathological Entities.

Authors:  Esperanza Mata-Martínez; Mauricio Díaz-Muñoz; Francisco G Vázquez-Cuevas
Journal:  Front Cell Neurosci       Date:  2022-06-16       Impact factor: 6.147

5.  A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans.

Authors:  Pooja Jadiya; Soobiya Fatima; Tanvi Baghel; Snober S Mir; Aamir Nazir
Journal:  Mol Neurobiol       Date:  2015-11-14       Impact factor: 5.590

Review 6.  A53T in a parkinsonian family: a clinical update of the SNCA phenotypes.

Authors:  Nicola Tambasco; Pasquale Nigro; Michele Romoli; Paolo Prontera; Simone Simoni; Paolo Calabresi
Journal:  J Neural Transm (Vienna)       Date:  2016-06-01       Impact factor: 3.575

7.  Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.

Authors:  Bruno A Benitez; Albert A Davis; Sheng Chih Jin; Laura Ibanez; Sara Ortega-Cubero; Pau Pastor; Jiyoon Choi; Breanna Cooper; Joel S Perlmutter; Carlos Cruchaga
Journal:  Mol Neurodegener       Date:  2016-04-19       Impact factor: 14.195

8.  Metallomic Biomarkers in Cerebrospinal fluid and Serum in patients with Parkinson's disease in Indian population.

Authors:  Jaya Sanyal; Shiek S S J Ahmed; Hon Keung Tony Ng; Tufan Naiya; Epsita Ghosh; Tapas Kumar Banerjee; Jaya Lakshmi; Gautam Guha; Vadlamudi Raghavendra Rao
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

9.  Outlining a Population "at Risk" of Parkinson's Disease: Evidence from a Case-Control Study.

Authors:  Tommaso Schirinzi; Giuseppina Martella; Alessio D'Elia; Giulia Di Lazzaro; Paola Imbriani; Graziella Madeo; Leonardo Monaco; Marta Maltese; Antonio Pisani
Journal:  Parkinsons Dis       Date:  2016-08-29

10.  Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease.

Authors:  Laura Ibanez; Umber Dube; Albert A Davis; Maria V Fernandez; John Budde; Breanna Cooper; Monica Diez-Fairen; Sara Ortega-Cubero; Pau Pastor; Joel S Perlmutter; Carlos Cruchaga; Bruno A Benitez
Journal:  Front Neurosci       Date:  2018-04-10       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.